Patrick Daly

DocwireNews

Patients with cancer face both physical and emotional challenges throughout their diagnosis and treatment. A recent study, led by Yıldız İpek, MD, sought to characterize any difference in anxiety levels between patients who were receiving either oral or intravenous (IV) chemotherapeutic agents for chronic lymphocytic leukemia (CLL).
In their analysis, featured at the 2023 Society of Hematologic Oncology Annual Meeting, Dr. İpek and colleagues determined that patients who were receiving IV treatments had higher anxiety scores compared with those receiving <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399396/" target="_blank" rel="noopener">oral treatments</a>. Additionally, patients who were previously treated had lower anxiety levels, “possibly due to their prior experience,” the authors suggested.
<h1>IV Cancer Treatments Associated with Increased Anxiety</h1>
Anxiety was observed in all patients, though authors noted female patients had generally higher levels of anxiety. “The presence of moderate and high-grade anxiety in both groups highlights the importance of a multidisciplinary approach, including psychiatry, in the comprehensive treatment of cancer,” the authors concluded.
The study enrolled 13 male and 8 female patients with a median age of 64.2 years who had a diagnosis within the past 5 years and no prior psychiatric treatments. Of the 21 patients, 10 were receiving first-line treatment and 11 had prior treatments and subsequent relapse. Oral cancer agents included ibrutinib, obinutuzumab venetoclax, and rituximab venetoclax. Participants’ degrees of anxiety were evaluated with multiple scoring tools at the start of treatment.
Overall, Dr. İpek and colleagues reported that “the study suggests that addressing anxiety is crucial for both patients and their relatives throughout the long and challenging cancer treatment process.”
Related: <a href="https://docwirenews.com/post/real-world-outcomes-of-ibrutinib-dose-reduction-versus-no-reduction-after-aes">Real-world Outcomes of Ibrutinib Dose Reduction Versus No Reduction After AEs</a>

Emily Menendez

Complete Response to Immunotherapy in HCC: Insights From IMbrave150

Hepatocellular Carcinoma

Anne Marie Morse, DO

Rob Dillard

Dr. Morse Talks About the Significance of World Sleep Day 2025

Sleep Disorders

Dr. John Fruehauf, Evolent

Advancing Therapies Have Improved the Prognosis of Metastatic Melanoma

Melanoma

Latest News

Difference in Anxiety Levels Between Oral, Intravenous Treatment in Patients With CLL

SOHO 2023

Data suggest patients with chronic lymphocytic leukemia experience more anxiety when receiving intravenous versus oral treatments.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe